Balanced Multi-Electrolyte Solution Versus Saline Trial for Diabetic KetoAcidosis
Status:
Not yet recruiting
Trial end date:
2025-09-01
Target enrollment:
Participant gender:
Summary
The goal of this blinded, cluster cross-over, randomised controlled trial is to determine
whether fluid therapy with Plasma-Lyte® 148 increases the number of days alive and days out
of hospital to day-28 compared to 0.9% sodium chloride ('0.9% saline') in critically ill
patients presenting to the Emergency Department (ED) and deemed to require admission to a
critical care area (ICU, HDU) with moderate to severe diabetic ketoacidosis (DKA).